Genetic Regulation of RIPK1 and Necroptosis.
MLKL
RIPK1
RIPK3
TNFR1
apoptosis
inflammation
necroptosis
neurodegeneration
Journal
Annual review of genetics
ISSN: 1545-2948
Titre abrégé: Annu Rev Genet
Pays: United States
ID NLM: 0117605
Informations de publication
Date de publication:
23 11 2021
23 11 2021
Historique:
entrez:
23
11
2021
pubmed:
24
11
2021
medline:
22
3
2022
Statut:
ppublish
Résumé
The receptor-interacting protein kinase 1 (RIPK1) is recognized as a master upstream regulator that controls cell survival and inflammatory signaling as well as multiple cell death pathways, including apoptosis and necroptosis. The activation of RIPK1 kinase is extensively modulated by ubiquitination and phosphorylation, which are mediated by multiple factors that also control the activation of the NF-κB pathway. We discuss current findings regarding the genetic modulation of RIPK1 that controls its activation and interaction with downstream mediators, such as caspase-8 and RIPK3, to promote apoptosis and necroptosis. We also address genetic autoinflammatory human conditions that involve abnormal activation of RIPK1. Leveraging these new genetic and mechanistic insights, we postulate how an improved understanding of RIPK1 biology may support the development of therapeutics that target RIPK1 for the treatment of human inflammatory and neurodegenerative diseases.
Identifiants
pubmed: 34813352
doi: 10.1146/annurev-genet-071719-022748
doi:
Substances chimiques
Protein Kinases
EC 2.7.-
RIPK1 protein, human
EC 2.7.11.1
Receptor-Interacting Protein Serine-Threonine Kinases
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM